EBOS Group Limited

Symbol: EBO.AX

ASX

31.74

AUD

Market price today

  • 23.3751

    P/E Ratio

  • -5.7269

    PEG Ratio

  • 6.13B

    MRK Cap

  • 0.03%

    DIV Yield

EBOS Group Limited (EBO-AX) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.07%

Operating Profit Margin

0.04%

Net Profit Margin

0.02%

Return on Assets

0.04%

Return on Equity

0.10%

Return on Capital Employed

0.11%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Distribution
CEO:Mr. John Cullity
Full-time employees:5000
City:Docklands
Address:737 Bourke Street
IPO:2013-12-05
CIK:

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, consumer, and animal care products in Australia and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and multi-brand retail pharmacy services. It also offers vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; community based health care services and programs; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers contract logistics services, such as healthcare distribution, warehousing, clinical trial management, and product registration services; and clinical trial logistics. Additionally, the company provides pet nutrition products, treats, clean-up products, grooming, and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

General Outlook

When we look at how much money they make before expenses, they keep 0.074% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.037%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.020%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.037% return, is a testament to EBOS Group Limited's adeptness in optimizing resource deployment. EBOS Group Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.097%. Furthermore, the proficiency of EBOS Group Limited in capital utilization is underscored by a remarkable 0.113% return on capital employed.

Stock Prices

EBOS Group Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $32.28, while its low point bottomed out at $31.62. This variance in figures offers investors a lucid insight into the roller-coaster ride that is EBOS Group Limited's stock market.

Liquidity Ratios

Analyzing EBO.AX liquidity ratios reveals its financial health of the firm. The current ratio of 113.12% gauges short-term asset coverage for liabilities. The quick ratio (64.31%) assesses immediate liquidity, while the cash ratio (7.97%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio113.12%
Quick Ratio64.31%
Cash Ratio7.97%

Profitability Ratios

EBO.AX profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 2.83% underscores its earnings before tax deductions. The effective tax rate stands at 30.52%, revealing its tax efficiency. The net income per EBT, 71.63%, and the EBT per EBIT, 77.24%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 3.67%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin2.83%
Effective Tax Rate30.52%
Net Income per EBT71.63%
EBT per EBIT77.24%
EBIT per Revenue3.67%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.13, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding64
Days of Inventory Outstanding42
Operating Cycle88.68
Days of Payables Outstanding71
Cash Conversion Cycle18
Receivables Turnover7.78
Payables Turnover5.17
Inventory Turnover8.74
Fixed Asset Turnover17.63
Asset Turnover1.81

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 1.73, and free cash flow per share, 1.06, depict cash generation on a per-share basis. The cash per share value, 1.20, showcases liquidity position. A payout ratio of 0.82 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.03, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share1.73
Free Cash Flow per Share1.06
Cash per Share1.20
Payout Ratio0.82
Operating Cash Flow Sales Ratio0.03
Free Cash Flow to Operating Cash Flow Ratio0.61
Cash Flow Coverage Ratio0.24
Short Term Coverage Ratio3.31
Capital Expenditure Coverage Ratio2.58
Dividend Paid and Capex Coverage Ratio0.98
Dividend Payout Ratio0.03

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 19.93%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.53, we discern the balance between debt and equity financing. The long-term debt to capitalization, 32.85%, and total debt to capitalization, 34.51%, ratios shed light on its capital structure. An interest coverage of 5.16 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio19.93%
Debt Equity Ratio0.53
Long Term Debt to Capitalization32.85%
Total Debt to Capitalization34.51%
Interest Coverage5.16
Cash Flow to Debt Ratio0.24
Company Equity Multiplier2.64

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 69.87, provides a glimpse into top-line earnings distributed across each share. Net income per share, 1.45, reflects the portion of profit attributed to each share. The book value per share, 13.90, represents the net asset value distributed per share, while the tangible book value per share, -1.07, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share69.87
Net Income Per Share1.45
Book Value Per Share13.90
Tangible Book Value Per Share-1.07
Shareholders Equity Per Share13.90
Interest Debt Per Share7.71
Capex Per Share-0.56

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 11.90%, indicates top-line expansion, while the gross profit growth, 23.05%, reveals profitability trends. EBIT growth, 35.45%, and operating income growth, 35.45%, offer insights into operational profitability progression. The net income growth, 22.74%, showcases bottom-line expansion, and the EPS growth, 14.17%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth11.90%
Gross Profit Growth23.05%
EBIT Growth35.45%
Operating Income Growth35.45%
Net Income Growth22.74%
EPS Growth14.17%
EPS Diluted Growth14.17%
Weighted Average Shares Growth7.74%
Weighted Average Shares Diluted Growth7.74%
Dividends per Share Growth3.88%
Operating Cash Flow Growth54.43%
Free Cash Flow Growth80.77%
10-Year Revenue Growth per Share104.63%
5-Year Revenue Growth per Share39.49%
3-Year Revenue Growth per Share20.32%
10-Year Operating CF Growth per Share351.41%
5-Year Operating CF Growth per Share92.69%
3-Year Operating CF Growth per Share47.17%
10-Year Net Income Growth per Share173.67%
5-Year Net Income Growth per Share46.94%
3-Year Net Income Growth per Share34.36%
10-Year Shareholders Equity Growth per Share143.27%
5-Year Shareholders Equity Growth per Share77.00%
3-Year Shareholders Equity Growth per Share59.55%
10-Year Dividend per Share Growth per Share151.38%
5-Year Dividend per Share Growth per Share51.40%
3-Year Dividend per Share Growth per Share35.42%
Receivables Growth6.92%
Inventory Growth8.16%
Asset Growth0.85%
Book Value per Share Growth-2.08%
Debt Growth-23.57%
SGA Expenses Growth23.81%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 8,188,914,349.571, captures the company's total value, considering both debt and equity. The ratio of intangibles to total assets, 38.71%, indicates the value of non-physical assets, and capex to operating cash flow, -25.13%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value8,188,914,349.571
Sales General and Administrative to Revenue0.04
Intangibles to Total Assets38.71%
Capex to Operating Cash Flow-25.13%
Capex to Revenue-0.80%
Graham Number21.27
Return on Tangible Assets6.42%
Graham Net Net-12.46
Working Capital379,610,404
Tangible Asset Value-204,888,454
Net Current Asset Value-1,226,244,423
Invested Capital1
Average Receivables1,576,977,601.5
Average Payables2,115,127,943
Average Inventory1,292,524,750.5
Days Sales Outstanding45
Days Payables Outstanding71
Days of Inventory On Hand42
ROIC8.63%
ROE0.10%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.27, and the price to book ratio, 2.27, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.48, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 29.73, and price to operating cash flows, 18.09, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.27
Price to Book Ratio2.27
Price to Sales Ratio0.48
Price Cash Flow Ratio18.09
Price Earnings to Growth Ratio-5.73
Enterprise Value Multiple8.25
Price Fair Value2.27
Price to Operating Cash Flow Ratio18.09
Price to Free Cash Flows Ratio29.73
Price to Tangible Book Ratio2.65
Enterprise Value to Sales0.61
Enterprise Value Over EBITDA12.98
EV to Operating Cash Flow19.23
Earnings Yield3.93%
Free Cash Flow Yield4.54%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of EBOS Group Limited (EBO.AX) on the ASX in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 23.375 in 2024.

What is the ticker symbol of EBOS Group Limited stock?

The ticker symbol of EBOS Group Limited stock is EBO.AX.

What is company IPO date?

IPO date of EBOS Group Limited is 2013-12-05.

What is company current share price?

Current share price is 31.740 AUD.

What is stock market cap today?

The market cap of stock today is 6133056720.000.

What is PEG ratio in 2024?

The current -5.727 is -5.727 in 2024.

What is the number of employees in 2024?

In 2024 the company has 5000.